Distinct signaling from stem cell factor and erythropoietin in HCD57 cells
Distinct signaling from stem cell factor and erythropoietin in HCD57 cells
复制标题
DOI:
10.1074/jbc.272.11.6850
复制
发表时间:
1997-03-14
影响因子:
4.8
通讯作者:
Sawyer, ST
中科院分区:
文献类型:
--
作者:
JacobsHelber, SM;Penta, K;Sawyer, ST
A recent report (Wu, H,, Klingmuller, U., Besmer, P., and Lodish, H, F. (1995) Nature 377, 242-246) documents the interaction of the erythropoietin (EPO) receptor (EPOR) with the stem cell factor (SCF) receptor (c-KIT) and suggests that SCF acts through the EPOR. To elucidate the ability of SCF to affect the erythropoietin signaling pathway, we studied the effect of SCF on EPOR phosphorylation, SHC/ERK-1 activity, and cell proliferation and apoptosis in EPO-dependent HCD57 cells, Treatment of these cells with SCF resulted in phosphorylation of the EPOR, However, SCF-dependent phosphorylation of the EPOR did not initiate an EPO-like intracellular signal. SCF induced proliferation, SHC phosphorylation, and activation of ERK-1 but did not activate the JAK/STAT pathway. SCF stimulated SHC phosphorylation and ERK-1 activation independent of the EPOR in cells where the EPOR was down-regulated; the presence of the EPOR appeared to facilitate SCF activation of SHC and ERK-1. Furthermore, treatment of HCD57 cells with SCF increased cell number over a 3-day treatment, but apoptosis was observed in these cells. These data may illustrate two distinct pathways for erythroid cell proliferation and prevention of apoptosis in response to EPO, thereby providing a system to discriminate these intracellular signals.